Litcius/Paper detail

Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening

Bhishem Thakur, Revansiddha Katte, Wang Xu, Katarzyna Janowska, Salam Sammour, Rory Henderson, Maolin Lu, Peter D. Kwong, Priyamvada Acharya

2025Nature Communications9 citationsDOIOpen Access PDF

Abstract

The hydrophobic fusion peptide (FP), a critical component of the HIV-1 entry machinery, is located at the N terminus of the envelope (Env) gp41 subunit. The receptor-binding gp120 subunit of Env forms a heterodimer with gp41. The gp120/gp41 heterodimer assembles into a homotrimer, in which FP is accessible for antibody binding. Env conformational changes or "opening" that follow receptor binding result in FP relocating to a newly formed interprotomer pocket at the gp41-gp120 interface where it is sterically inaccessible to antibodies. The mechanistic steps connecting the entry-related transition of antibody accessible-to-inaccessible FP configurations remain unresolved. Here, using SOSIP-stabilized Env ectodomains, we visualize that the FP remains accessible for antibody binding despite substantial receptor-induced Env opening. We delineate stepwise Env opening from its closed state to a functional CD4-bound symmetrically open Env in which we show that FP was accessible for antibody binding. We define downstream re-organizations that lead to the formation of a gp120/gp41 cavity into which the FP buries to become inaccessible for antibody binding. These findings improve our understanding of HIV-1 entry and delineate the entry-related conformational trajectory of a key site of HIV vulnerability to neutralizing antibody.

Topics & Concepts

Envelope (radar)FusionTrajectoryHuman immunodeficiency virus (HIV)PeptidePhysicsBiophysicsCell biologyVirologyBiologyComputer scienceNuclear magnetic resonanceTelecommunicationsQuantum mechanicsPhilosophyLinguisticsRadarHIV Research and TreatmentHIV/AIDS drug development and treatmentMonoclonal and Polyclonal Antibodies Research
Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening | Litcius